Signaling Pathway
- Rheumatoid Arthritis
Anti-rheumatic drug as a potential candidate for treating COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produces inflammatory cytokine storms. But an FDA-approved anti-rheumatic drug, Auranofin, used to…
Read More »
